Ronald N. Spaulding's most recent trade in Atrion Corp. was a trade of 2,678 common stock done at an average price of $460 . Disclosure was reported to the exchange on Aug. 21, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Atrion Corp | Ronald N. Spaulding | Director | Sale or transfer of securities back to the company at price $ 460.00 per share. | 21 Aug 2024 | 2,678 | 0 (0%) | 0% | 460 | 1,231,880 | common stock |
Atrion Corp | Ronald N. Spaulding | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Aug 2024 | 312 | 0 | - | - | Deferred Stock Unit | |
Atrion Corp | Ronald N. Spaulding | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 311 | 311 | - | - | Deferred Stock Unit | |
Atrion Corp | Ronald N. Spaulding | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 224 | 2,678 (0%) | 0% | 0 | Common Stock | |
Atrion Corp | Ronald N. Spaulding | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 172 | 2,454 (0%) | 0% | 0 | Common Stock | |
Atrion Corp | Ronald N. Spaulding | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2021 | 154 | 2,282 (0%) | 0% | 0 | Common Stock | |
Atrion Corp | Ronald N. Spaulding | Director | Sale or transfer of securities back to the company at price $ 639.38 per share. | 29 Dec 2020 | 117 | 2,128 (0%) | 0% | 639.4 | 74,807 | Common Stock |